• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙肝表面抗原表达通过降低溶酶体相关膜蛋白2(LAMP2)来损害内质网应激相关的自噬通量。

Hepatitis B surface antigen expression impairs endoplasmic reticulum stress-related autophagic flux by decreasing LAMP2.

作者信息

Liang Yaojie, Luo Xufeng, Schefczyk Stefan, Muungani Lorraine T, Deng Hui, Wang Baoju, Baba Hideo A, Lu Mengji, Wedemeyer Heiner, Schmidt Hartmut H, Broering Ruth

机构信息

Department of Gastroenterology, Hepatology and Transplant Medicine, Medical Faculty, University of Duisburg-Essen, Essen, Germany.

Institute for Lymphoma Research, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.

出版信息

JHEP Rep. 2024 Jan 28;6(4):101012. doi: 10.1016/j.jhepr.2024.101012. eCollection 2024 Apr.

DOI:10.1016/j.jhepr.2024.101012
PMID:38425451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10899050/
Abstract

BACKGROUND & AIMS: Hepatitis B surface antigen (HBsAg) drives hepatocarcinogenesis. Factors and mechanisms involved in this progression remain poorly defined, hindering the development of effective therapeutic strategies. Therefore, the mechanisms involved in the HBsAg-induced transformation of normal liver into hepatocellular carcinoma (HCC) were investigated.

METHODS

Hemizygous Tg(Alb1HBV)44Bri/J mice were examined for HBsAg-induced carcinogenic events. Gene set-enrichment analysis identified significant signatures in HBsAg-transgenic mice that correlated with endoplasmic reticulum (ER) stress, unfolded protein response, autophagy and proliferation. These events were investigated by western blotting, immunohistochemical and immunocytochemical staining in 2-, 8- and 12-month-old HBsAg-transgenic mice. The results were verified in HBsAg-overexpressing Hepa1-6 cells and validated in human HBV-related HCC samples.

RESULTS

Increased BiP expression in HBsAg-transgenic mice indicated induction of the unfolded protein response. In addition, early-phase autophagy was enhanced (increased BECN1 and LC3B) and late-phase autophagy blocked (increased p62) in HBsAg-transgenic mice. Finally, HBsAg altered lysosomal acidification via ATF4- and ATF6-mediated downregulation of lysosome-associated membrane protein 2 (LAMP2) expression. In patients, HBV-related HCC and adjacent tissues showed increased BiP, p62 and downregulated LAMP2 compared to uninfected controls. the use of ER stress inhibitors reversed the HBsAg-related suppression of LAMP2. Furthermore, HBsAg promoted hepatocellular proliferation as indicated by Ki67, cleaved caspase-3 and AFP staining in paraffin-embedded liver sections from HBsAg-transgenic mice. These results were further verified by colony formation assays in HBsAg-expressing Hepa1-6 cells. Interestingly, inhibition of ER stress in HBsAg-overexpressing Hepa1-6 cells suppressed HBsAg-mediated cell proliferation.

CONCLUSIONS

These data showed that HBsAg directly induces ER stress, impairs autophagy and promotes proliferation, thereby driving hepatocarcinogenesis. In addition, this study expanded the understanding of HBsAg-mediated intracellular events in carcinogenesis.

IMPACT AND IMPLICATIONS

Factors and mechanisms involved in hepatocarcinogenesis driven by hepatitis B surface antigen (HBsAg) are poorly defined, hindering the development of effective therapeutic strategies. This study showed that HBsAg-induced endoplasmic reticulum stress suppressed LAMP2, thereby mediating autophagic injury. The present data suggest that restoring LAMP2 function in chronic HBV infection may have both antiviral and anti-cancer effects. This study has provided insights into the role of HBsAg-mediated intracellular events in carcinogenesis and thereby has relevance for future drug development.

摘要

背景与目的

乙型肝炎表面抗原(HBsAg)驱动肝癌发生。这一进程中涉及的因素和机制仍不清楚,阻碍了有效治疗策略的开发。因此,我们研究了HBsAg诱导正常肝脏转变为肝细胞癌(HCC)的机制。

方法

对半合子Tg(Alb1HBV)44Bri/J小鼠进行检查,以研究HBsAg诱导的致癌事件。基因集富集分析确定了HBsAg转基因小鼠中与内质网(ER)应激、未折叠蛋白反应、自噬和增殖相关的显著特征。通过蛋白质免疫印迹法、免疫组织化学和免疫细胞化学染色对2个月、8个月和12个月大的HBsAg转基因小鼠进行研究这些事件。结果在过表达HBsAg的Hepa1-6细胞中得到验证,并在人类HBV相关HCC样本中得到证实。

结果

HBsAg转基因小鼠中BiP表达增加表明未折叠蛋白反应被诱导。此外,HBsAg转基因小鼠早期自噬增强(BECN1和LC3B增加),晚期自噬受阻(p62增加)。最后,HBsAg通过ATF4和ATF6介导的溶酶体相关膜蛋白2(LAMP2)表达下调改变溶酶体酸化。在患者中,与未感染对照相比,HBV相关HCC及相邻组织中BiP、p62增加,LAMP2下调。使用ER应激抑制剂可逆转HBsAg相关的LAMP2抑制。此外,如在HBsAg转基因小鼠石蜡包埋肝切片中通过Ki67、裂解的半胱天冬酶-3和甲胎蛋白染色所示,HBsAg促进肝细胞增殖。这些结果在过表达HBsAg的Hepa1-6细胞的集落形成试验中得到进一步验证。有趣的是,在过表达HBsAg的Hepa1-6细胞中抑制ER应激可抑制HBsAg介导的细胞增殖。

结论

这些数据表明,HBsAg直接诱导ER应激、损害自噬并促进增殖,从而驱动肝癌发生。此外,本研究扩展了对HBsAg介导的致癌过程中细胞内事件的理解。

影响与意义

乙型肝炎表面抗原(HBsAg)驱动的肝癌发生所涉及的因素和机制尚不明确,阻碍了有效治疗策略的开发。本研究表明,HBsAg诱导的内质网应激抑制LAMP2,从而介导自噬损伤。目前的数据表明,在慢性HBV感染中恢复LAMP2功能可能具有抗病毒和抗癌作用。本研究为HBsAg介导的细胞内事件在致癌过程中的作用提供了见解,从而与未来的药物开发相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/305d7d17301a/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/f6987a51a438/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/81e87729f7aa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/969d8f26e23c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/a84a688f8c53/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/b41c80e2cf31/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/e1c30f09c7b3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/f644e44db027/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/6cfdc73aed8d/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/305d7d17301a/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/f6987a51a438/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/81e87729f7aa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/969d8f26e23c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/a84a688f8c53/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/b41c80e2cf31/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/e1c30f09c7b3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/f644e44db027/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/6cfdc73aed8d/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac82/10899050/305d7d17301a/gr8.jpg

相似文献

1
Hepatitis B surface antigen expression impairs endoplasmic reticulum stress-related autophagic flux by decreasing LAMP2.乙肝表面抗原表达通过降低溶酶体相关膜蛋白2(LAMP2)来损害内质网应激相关的自噬通量。
JHEP Rep. 2024 Jan 28;6(4):101012. doi: 10.1016/j.jhepr.2024.101012. eCollection 2024 Apr.
2
HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression.HMMR 通过促进内质网应激驱动的肝癌进展过程中的自噬溶酶体活性来缓解内质网应激。
Cancer Commun (Lond). 2023 Sep;43(9):981-1002. doi: 10.1002/cac2.12464. Epub 2023 Jul 5.
3
Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.乙型肝炎病毒小包膜蛋白通过内质网应激信号促进肝细胞癌血管生成以上调血管内皮生长因子 A 的表达。
J Virol. 2022 Feb 23;96(4):e0197521. doi: 10.1128/JVI.01975-21. Epub 2021 Dec 15.
4
Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen.干扰素信号抑制未折叠蛋白反应并诱导积累乙型肝炎表面抗原的肝细胞死亡。
PLoS Pathog. 2021 May 12;17(5):e1009228. doi: 10.1371/journal.ppat.1009228. eCollection 2021 May.
5
Fatty Acids Inhibit LAMP2-Mediated Autophagy Flux via Activating ER Stress Pathway in Alcohol-Related Liver Disease.脂肪酸通过激活酒精性肝病中的内质网应激通路抑制 LAMP2 介导线粒体自噬流。
Cell Mol Gastroenterol Hepatol. 2021;12(5):1599-1615. doi: 10.1016/j.jcmgh.2021.07.002. Epub 2021 Jul 17.
6
CCDC88A/GIV promotes HBV replication and progeny secretion via enhancing endosomal trafficking and blocking autophagic degradation.CCDC88A/GIV 通过增强内体运输和阻断自噬降解促进 HBV 复制和子代分泌。
Autophagy. 2022 Feb;18(2):357-374. doi: 10.1080/15548627.2021.1934271. Epub 2021 Jun 30.
7
Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.乙型肝炎病毒编码的 HBsAg 通过 NF-κB 通路诱导致癌长非编码 RNA LINC00665 促进肝癌发生。
Microbiol Spectr. 2022 Oct 26;10(5):e0273121. doi: 10.1128/spectrum.02731-21. Epub 2022 Aug 22.
8
Apolipoprotein H drives hepatitis B surface antigen retention and endoplasmic reticulum stress during hepatitis B virus infection.载脂蛋白 H 在乙型肝炎病毒感染期间驱动乙型肝炎表面抗原的保留和内质网应激。
Int J Biochem Cell Biol. 2021 Feb;131:105906. doi: 10.1016/j.biocel.2020.105906. Epub 2020 Dec 26.
9
Endoplasmic reticulum stress promotes HBV production by enhancing use of the autophagosome/multivesicular body axis.内质网应激通过增强自噬体/多泡体轴的使用促进 HBV 的产生。
Hepatology. 2022 Feb;75(2):438-454. doi: 10.1002/hep.32178. Epub 2021 Dec 18.
10
Nuclear translocation of YAP drives BMI-associated hepatocarcinogenesis in hepatitis B virus infection.YAP 的核转位驱动乙型肝炎病毒感染相关 BMI 肝癌发生。
Liver Int. 2023 Sep;43(9):2002-2016. doi: 10.1111/liv.15628. Epub 2023 Jun 14.

引用本文的文献

1
HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression.乙肝病毒核心蛋白增强WDR46稳定性以上调NUSAP1并促进肝癌进展。
Hepatol Commun. 2025 May 6;9(5). doi: 10.1097/HC9.0000000000000680. eCollection 2025 May 1.
2
The endoplasmic reticulum degradation-enhancing α-mannosidase-like protein 3 attenuates the unfolded protein response and has pro-survival and pro-viral roles in hepatoma cells and hepatocellular carcinoma patients.内质网降解增强α-甘露糖苷酶样蛋白3减弱未折叠蛋白反应,并在肝癌细胞和肝细胞癌患者中具有促生存和促病毒作用。
J Biomed Sci. 2025 Jan 22;32(1):11. doi: 10.1186/s12929-024-01103-9.
3

本文引用的文献

1
Nuclear translocation of YAP drives BMI-associated hepatocarcinogenesis in hepatitis B virus infection.YAP 的核转位驱动乙型肝炎病毒感染相关 BMI 肝癌发生。
Liver Int. 2023 Sep;43(9):2002-2016. doi: 10.1111/liv.15628. Epub 2023 Jun 14.
2
Impaired degradation of YAP1 and IL6ST by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells.伴侣蛋白介导的自噬作用降低 YAP1 和 IL6ST 的降解,促进正常和肝癌细胞的增殖和迁移。
Autophagy. 2023 Jan;19(1):152-162. doi: 10.1080/15548627.2022.2063004. Epub 2022 Apr 18.
3
In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma.
Engineered extracellular vesicles as nanosponges for lysosomal degradation of PCSK9.
工程化细胞外囊泡作为纳米海绵用于PCSK9的溶酶体降解
Mol Ther. 2025 Feb 5;33(2):471-484. doi: 10.1016/j.ymthe.2024.11.034. Epub 2024 Nov 26.
4
Hepatitis B virus entry, assembly, and egress.乙型肝炎病毒的进入、组装和释放。
Microbiol Mol Biol Rev. 2024 Dec 18;88(4):e0001424. doi: 10.1128/mmbr.00014-24. Epub 2024 Oct 23.
乙型肝炎病毒(HBV)抗原和 DNA 在 HBV 诱导的肝细胞癌中的原位分析。
Diagn Pathol. 2022 Jan 16;17(1):11. doi: 10.1186/s13000-022-01194-8.
4
ER-Phagy and Microbial Infection.内质网自噬与微生物感染
Front Cell Dev Biol. 2021 Nov 29;9:771353. doi: 10.3389/fcell.2021.771353. eCollection 2021.
5
ERK5 Inhibition Induces Autophagy-Mediated Cancer Cell Death by Activating ER Stress.ERK5抑制通过激活内质网应激诱导自噬介导的癌细胞死亡。
Front Cell Dev Biol. 2021 Nov 4;9:742049. doi: 10.3389/fcell.2021.742049. eCollection 2021.
6
Fatty Acids Inhibit LAMP2-Mediated Autophagy Flux via Activating ER Stress Pathway in Alcohol-Related Liver Disease.脂肪酸通过激活酒精性肝病中的内质网应激通路抑制 LAMP2 介导线粒体自噬流。
Cell Mol Gastroenterol Hepatol. 2021;12(5):1599-1615. doi: 10.1016/j.jcmgh.2021.07.002. Epub 2021 Jul 17.
7
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
8
Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma.鉴定与肝细胞癌发病机制和预后相关的潜在关键基因。
J Clin Pathol. 2021 Aug;74(8):504-512. doi: 10.1136/jclinpath-2020-206979. Epub 2020 Oct 1.
9
The Lysosomal Membrane Protein Lamp2 Alleviates Lysosomal Cell Death by Promoting Autophagic Flux in Ischemic Cardiomyocytes.溶酶体膜蛋白Lamp2通过促进缺血性心肌细胞的自噬通量减轻溶酶体细胞死亡。
Front Cell Dev Biol. 2020 Feb 7;8:31. doi: 10.3389/fcell.2020.00031. eCollection 2020.
10
Therapeutic strategies for hepatitis B virus infection: towards a cure.乙型肝炎病毒感染的治疗策略:迈向治愈。
Nat Rev Drug Discov. 2019 Nov;18(11):827-844. doi: 10.1038/s41573-019-0037-0. Epub 2019 Aug 27.